Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close down 0.19%
10/31/2025 02:23 PM - Culture
Sweet discovery! Tainan project unearths historical sugar industry ruins
10/31/2025 02:09 PM - Politics
Special bill on Hualien post-flood reconstruction clears Legislature
10/31/2025 02:04 PM - Society
Meta warns of scams ahead of Taiwan's NT10,000 cash handout
10/31/2025 12:44 PM - Business
U.S. dollar up in Taipei trading
10/31/2025 10:10 AM